VAERS reports by lot

Moderna COVID-19 lot 041821A: VAERS reports

25 VAERS reports list lot 041821A as a Moderna COVID-19 vaccine, received between 2021-04-12 and 2022-05-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
16%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1828%
Neurological1117%
Cardiac / Cardiovascular711%
Gastrointestinal69%
Dermatological (non-injection-site)69%
Injection-site / Local reaction69%
Musculoskeletal58%
Allergic / Anaphylactic35%
Thrombotic / Hematological12%
Psychiatric / Neuropsychiatric12%
Reproductive / Menstrual12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California8
Arizona4
Florida3
Colorado1
South Carolina1
Indiana1
Georgia1
Maryland1
Kentucky1
Iowa1
Alabama1
Montana1

Reports by month received

2021-048
2021-051
2021-061
2021-088
2021-091
2021-102
2022-012
2022-031
2022-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.